AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26308490 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate, 4%, with 3 showers and a 1-minute pause before rinsing
Number of subjects: 120
Study 26308490 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate, 4%, with 3 showers and a 2-minute pause before rinsing
Number of subjects: 120
Study 26308490 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate, 4%, with 3 showers and no pause before rinsing
Number of subjects: 120
Study 23247745 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin acid
Number of subjects: 20
Study 21752665 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermia with intermittent warm blood cardioplegia (IWBC)
Number of subjects: 47
Study 21752665 — intervention group
Group type: COMPARATOR
Intervention: Cold crystalloid cardioplegia (CCC)
Number of subjects: 47
Study 21752665 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IWBC and CCC)
Number of subjects: 47
Study 18579440 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transmitral filling (RF) pattern (DT <= 140 ms)
Number of subjects: 972
Study 18579440 — intervention group
Group type: COMPARATOR
Intervention: Non-restrictive transmitral filling (non-RF) pattern (DT > 140 ms)
Number of subjects: 972
Study 18579440 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed relaxation (DT > 240 ms)
Number of subjects: 972
Study 18579440 — intervention group
Group type: EXPERIMENTAL
Intervention: RF in patients with LVEF >= 50%
Number of subjects: 972
Study 16472981 — intervention group
Group type: EXPERIMENTAL
Intervention: Perilla oil
Number of subjects: 30
Study 16472981 — intervention group
Group type: COMPARATOR
Intervention: Soybean oil
Number of subjects: 30
Study 12620529 — intervention group
Group type: EXPERIMENTAL
Intervention: Apples
Number of subjects: 411
Study 12620529 — intervention group
Group type: EXPERIMENTAL
Intervention: Pears
Number of subjects: 411
Study 12620529 — intervention group
Group type: COMPARATOR
Intervention: Oat cookies
Number of subjects: 411
Study 12821234 — intervention group
Group type: EXPERIMENTAL
Intervention: Beraprost sodium (median dose 120 microg four times a day)
Number of subjects: 116
Study 12821234 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 10813099 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms of ethinyl estradiol (EE) and 1 mg of norethindrone (NET) from days 6 through 10 (Group I)
Number of subjects: 10
Study 10813099 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms of ethinyl estradiol (EE) and 1 mg of norethindrone (NET) from days 8 through 12 (Group II)
Number of subjects: 10
Study 10813099 — intervention group
Group type: COMPARATOR
Intervention: Both groups (I and II)
Number of subjects: 10
Study 8880281 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol processing system (ProtoVIEW)
Number of subjects: 0
Study 1649148 — intervention group
Group type: EXPERIMENTAL
Intervention: Local injection of beta‐IFN through an Ommaya reservoir
Number of subjects: 28
Study 1649148 — intervention group
Group type: EXPERIMENTAL
Intervention: beta‐IFN followed by systemic chemotherapy (Cisplatin + Etoposide)
Number of subjects: 28
Study 1649148 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy only
Number of subjects: 28
Study 6439234 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) administered as a dry powder via the spinhaler
Number of subjects: 0
Study 6439234 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30412077 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose of 0.8 μg/kg, pumped for over 10 minutes)
Number of subjects: 0
Study 30412077 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (same volume pumped for 10 minutes)
Number of subjects: 0
Study 26714803 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine with adrenaline
Number of subjects: 82
Study 26714803 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 82
Study 24460799 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 180
Study 24460799 — intervention group
Group type: COMPARATOR
Intervention: Former and never smokers
Number of subjects: 180
Study 21868590 — intervention group
Group type: EXPERIMENTAL
Intervention: Group visits conducted by 9 residents
Number of subjects: 7
Study 19658043 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/day Zn as Zn sulfate
Number of subjects: 84
Study 19658043 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 18042894 — intervention group
Group type: EXPERIMENTAL
Intervention: Paramedian approach (Group PM)
Number of subjects: 40
Study 18042894 — intervention group
Group type: COMPARATOR
Intervention: Midline approach (Group M)
Number of subjects: 40
Study 18042894 — intervention group
Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 40
Study 15848920 — intervention group
Group type: EXPERIMENTAL
Intervention: Traveling Vision Examiner (TVE) Program
Number of subjects: 239
Study 15848920 — intervention group
Group type: COMPARATOR
Intervention: Local vision examiners
Number of subjects: 239
Study 12153804 — intervention group
Group type: EXPERIMENTAL
Intervention: ERM peeling
Number of subjects: 91
Study 12153804 — intervention group
Group type: COMPARATOR
Intervention: No ERM peeling
Number of subjects: 91
Study 12153804 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative ERMs
Number of subjects: 91
Study 12153804 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative hole size
Number of subjects: 91
Study 9872200 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation (NPPV)
Number of subjects: 30
Study 9872200 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (ST)
Number of subjects: 30
Study 8551652 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine aspartate (17 g free arginine)
Number of subjects: 45
Study 8551652 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 2164652 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% trichloroacetic acid (single topical application)
Number of subjects: 34
Study 2164652 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo, single topical application)
Number of subjects: 34
Study 626331 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal block in the lateral position combined with light sedation
Number of subjects: 55
Study 626331 — intervention group
Group type: COMPARATOR
Intervention: Standard general anaesthetic
Number of subjects: 55
Study 31172638 — intervention group
Group type: EXPERIMENTAL
Intervention: Provisional phase with soft tissue conditioning using the 'dynamic compression technique'
Number of subjects: 20
Study 31172638 — intervention group
Group type: COMPARATOR
Intervention: No provisional phase
Number of subjects: 20
Study 29354969 — intervention group
Group type: EXPERIMENTAL
Intervention: Touching-periosteum needling technique and rehabilitation training
Number of subjects: 106
Study 29354969 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture and rehabilitation training
Number of subjects: 106
Study 25925019 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper thoracic manipulation (single session administered to the T1 vertebral area)
Number of subjects: 32
Study 25925019 — intervention group
Group type: COMPARATOR
Intervention: Sham manipulation (placebo)
Number of subjects: 32
Study 23910205 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified transpalatal arch supported by 2 midpalatal miniscrews
Number of subjects: 51
Study 23910205 — intervention group
Group type: COMPARATOR
Intervention: High-pull headgear
Number of subjects: 51
Study 21590643 — intervention group
Group type: EXPERIMENTAL
Intervention: Lentils (LGI)
Number of subjects: 9
Study 21590643 — intervention group
Group type: EXPERIMENTAL
Intervention: Potatoes (HGI)
Number of subjects: 9
Study 21590643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 18638631 — intervention group
Group type: EXPERIMENTAL
Intervention: Desonide foam 0.05%
Number of subjects: 75
Study 18638631 — intervention group
Group type: COMPARATOR
Intervention: Vehicle foam (control)
Number of subjects: 75
Study 16434864 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 10 mg b.i.d.
Number of subjects: 110
Study 16434864 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 300 mg b.i.d.
Number of subjects: 110
Study 12576428 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib (400 or 600 mg/day)
Number of subjects: 19
Study 12576428 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin (CLI)
Number of subjects: 19
Study 11314831 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (1 microg/kg), midazolam (0.05 to 0.075 mg/kg), and propofol (10 to 20 mg boluses as required)
Number of subjects: 69
Study 11314831 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane in 67% nitrous oxide
Number of subjects: 69
Study 9173635 — intervention group
Group type: EXPERIMENTAL
Intervention: Community psychiatric treatment
Number of subjects: 0
Study 9173635 — intervention group
Group type: COMPARATOR
Intervention: Control district (no community psychiatric treatment)
Number of subjects: 0
Study 9173635 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenic patients
Number of subjects: 0
Study 7892802 — intervention group
Group type: EXPERIMENTAL
Intervention: PREP for Effective Family Living Program (treatment group)
Number of subjects: 9
Study 7892802 — intervention group
Group type: COMPARATOR
Intervention: Prenatal course without PREP program (comparison group)
Number of subjects: 9
Study 7892802 — intervention group
Group type: COMPARATOR
Intervention: No attendance to either prenatal course or PREP program (comparison group)
Number of subjects: 9
Study 3295380 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin treatment at a dose of 164.50 +/- 24.55 mg/kg body weight
Number of subjects: 20
Study 3295380 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin treatment at a dose of 359.65 +/- 58.62 mg/kg body weight
Number of subjects: 20
Study 3295380 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin treatment
Number of subjects: 20
Study 2285464 — intervention group
Group type: COMPARATOR
Intervention: ORS‐90 (oral rehydration solution recommended by WHO)
Number of subjects: 186
Study 2285464 — intervention group
Group type: EXPERIMENTAL
Intervention: ORS‐60 (60 mmol/L sodium and 90 mmol/L glucose)
Number of subjects: 186
Study 2285464 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ORS‐90 and ORS‐60
Number of subjects: 186
Study 16800 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant 1
Number of subjects: 120
Study 16800 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant 2
Number of subjects: 120
Study 16800 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant 3
Number of subjects: 120
Study 16800 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant 4
Number of subjects: 120
Study 16800 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant 5
Number of subjects: 120
Study 16800 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant 6
Number of subjects: 120
Study 31106486 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patches
Number of subjects: 268
Study 31106486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study 27829521 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxed-arm (N=69)
Number of subjects: 143
Study 27829521 — intervention group
Group type: COMPARATOR
Intervention: Incremental-arm (N=74)
Number of subjects: 143
Study 27829521 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants with preoperative serum chloride < 100mmol/L
Number of subjects: 143
Study 26077436 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac sodium 2% solution (40.4 mg/2 mL) BID for 7.5 days
Number of subjects: 76
Study 26077436 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac sodium 1.5% solution (19.3 mg/40 drops) QID for 7.5 days
Number of subjects: 76
Study 26077436 — intervention group
Group type: COMPARATOR
Intervention: Oral diclofenac sodium 75 mg BID for 7.5 days
Number of subjects: 76
Study 23790158 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent ratings of adolescents’ daily behaviors associated with executive functioning (EF)
Number of subjects: 132
Study 23790158 — intervention group
Group type: EXPERIMENTAL
Intervention: Common measure of verbal memory
Number of subjects: 132
Study 21860559 — intervention group
Group type: EXPERIMENTAL
Intervention: DA-9601 60 mg three times daily
Number of subjects: 266
Study 21860559 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol 200 µg three times daily
Number of subjects: 266
Study 19219495 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasogastric tube (NG tube)
Number of subjects: 0
Study 19219495 — intervention group
Group type: COMPARATOR
Intervention: No nasogastric tube (NG tube)
Number of subjects: 0
Study 17092740 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg oral dose
Number of subjects: 15
Study 12842515 — intervention group
Group type: EXPERIMENTAL
Intervention: Starr Edwards prosthesis
Number of subjects: 267
Study 12842515 — intervention group
Group type: COMPARATOR
Intervention: St. Jude prosthesis
Number of subjects: 267
Study 10803439 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with stable CAD (n=54)
Number of subjects: 110
Study 10803439 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with unstable CAD (n=56)
Number of subjects: 110
Study 10803439 — intervention group
Group type: COMPARATOR
Intervention: Controls (n=49)
Number of subjects: 110
Study 10803439 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with unstable angina (n=49)
Number of subjects: 110
Study 8888028 — intervention group
Group type: EXPERIMENTAL
Intervention: Urokinase (420,000 units over two days)
Number of subjects: 34
Study 8888028 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium ozagrel (160 mg/day for two weeks)
Number of subjects: 34
Study 8888028 — intervention group
Group type: EXPERIMENTAL
Intervention: Urokinase
Number of subjects: 34
Study 8888028 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium ozagrel
Number of subjects: 34
Study 1889274 — intervention group
Group type: EXPERIMENTAL
Intervention: EnsurePlus HN (E)
Number of subjects: 12
Study 1889274 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmocare (P)
Number of subjects: 12
Study 1889274 — intervention group
Group type: COMPARATOR
Intervention: Noncaloric placebo (C)
Number of subjects: 12
Study 6220603 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxalactam (250 mg every 12 hours)
Number of subjects: 111
Study 6220603 — intervention group
Group type: COMPARATOR
Intervention: Tobramycin (1.0 mg/kg every eight hours)
Number of subjects: 111
Study 6220603 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxalactam
Number of subjects: 111
Study 6220603 — intervention group
Group type: COMPARATOR
Intervention: Tobramycin
Number of subjects: 111
Study 30448455 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss (≥5% weight loss in 1 year)
Number of subjects: 242
Study 30448455 — intervention group
Group type: COMPARATOR
Intervention: No weight loss (<5% weight loss in 1 year)
Number of subjects: 242
Study 28869119 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation (3 sessions weekly for 8 weeks, aerobic exercise for 20min at 60-80% max stepping rate, resistance training with elastic band at 70% max voluntary isometric contraction)
Number of subjects: 48
Study 28869119 — intervention group
Group type: COMPARATOR
Intervention: Standard care (educational manual and recommendation to walk 3 times a week for 30min)
Number of subjects: 48
Study 26375919 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (RESEX)
Number of subjects: 34
Study 26375919 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent exercise (CONCEX)
Number of subjects: 34
Study 26375919 — intervention group
Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 34
Study 23208878 — intervention group
Group type: EXPERIMENTAL
Intervention: New live tetravalent dengue virus vaccine
Number of subjects: 86
Study 23208878 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 86
Study 21810233 — intervention group
Group type: EXPERIMENTAL
Intervention: NEURAPAS® balance (6 tablets)
Number of subjects: 16
Study 21810233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 19371497 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (8 mg/day)
Number of subjects: 100
Study 19371497 — intervention group
Group type: COMPARATOR
Intervention: Chlordiazepoxide (80 mg/day)
Number of subjects: 100
Study 19371497 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 100
Study 19371497 — intervention group
Group type: COMPARATOR
Intervention: Chlordiazepoxide
Number of subjects: 100
Study 19371497 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 100
Study 16413241 — intervention group
Group type: EXPERIMENTAL
Intervention: AVE7688 25 mg
Number of subjects: 0
Study 16413241 — intervention group
Group type: EXPERIMENTAL
Intervention: AVE7688 5 mg
Number of subjects: 0
Study 15571611 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger root powder 1 g/day for 5 days
Number of subjects: 48
Study 15571611 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (oral) for 4 days after placebo on the first day
Number of subjects: 48
Study 10594428 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural group (n = 69)
Number of subjects: 142
Study 10594428 — intervention group
Group type: COMPARATOR
Intervention: Epidural group (n = 73)
Number of subjects: 142
Study 10594428 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 142
Study 9339153 — intervention group
Group type: EXPERIMENTAL
Intervention: HVB suppositories
Number of subjects: 25
Study 9339153 — intervention group
Group type: EXPERIMENTAL
Intervention: PGB suppositories
Number of subjects: 25
Study 9339153 — intervention group
Group type: EXPERIMENTAL
Intervention: TVC mini-enemas
Number of subjects: 25
Study 8232678 — intervention group
Group type: EXPERIMENTAL
Intervention: HELP treatment
Number of subjects: 45
Study 8232678 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 3886069 — intervention group
Group type: EXPERIMENTAL
Intervention: Excision with suture (E + S)
Number of subjects: 88
Study 3886069 — intervention group
Group type: COMPARATOR
Intervention: Excision (E)
Number of subjects: 88
Study 3886069 — intervention group
Group type: EXPERIMENTAL
Intervention: Excision with suture under cover with clindamycin (E + S + C)
Number of subjects: 88
Study 31631005 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity continuous exercise
Number of subjects: 22
Study 31631005 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intensity interval exercise
Number of subjects: 22
Study 31631005 — intervention group
Group type: COMPARATOR
Intervention: Seated rest
Number of subjects: 22
Study 30917079 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod
Number of subjects: 0
Study 30917079 — intervention group
Group type: COMPARATOR
Intervention: IM IFNβ‐1a
Number of subjects: 0
Study 27781297 — intervention group
Group type: EXPERIMENTAL
Intervention: Single MAC3.5 guiding catheter
Number of subjects: 360
Study 27781297 — intervention group
Group type: COMPARATOR
Intervention: Control group (diagnostic Tiger catheter first)
Number of subjects: 360
Study 26694377 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin α (DA)
Number of subjects: 20
Study 26694377 — intervention group
Group type: COMPARATOR
Intervention: Continuous Erythropoietin Receptor Activator (CERA)
Number of subjects: 20
Study 23395398 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 1103
Study 21999340 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine 0.05% (Cs-Cs)
Number of subjects: 48
Study 21999340 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears (Cs-At)
Number of subjects: 48
Study 21999340 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine 0.05% after switching from artificial tears (At-Cs)
Number of subjects: 48
Study 18652095 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Chih
Number of subjects: 112
Study 18652095 — intervention group
Group type: COMPARATOR
Intervention: Health education
Number of subjects: 112
Study 17062808 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized Polar weight management program (PWMP)
Number of subjects: 74
Study 17062808 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 74
Study 12619144 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week supervised aerobic exercise program
Number of subjects: 24
Study 12619144 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 24
Study 11199239 — intervention group
Group type: EXPERIMENTAL
Intervention: One-day workshop or two half-day workshops on cancer pain assessment and management
Number of subjects: 496
Study 11199239 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside-precepted visit with an oncology nurse specialist and focus group discussion
Number of subjects: 496
Study 11199239 — intervention group
Group type: COMPARATOR
Intervention: Control group (86 nurses)
Number of subjects: 496
Study 9425672 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating walls in a moving room for 12 seconds
Number of subjects: 4
Study 8281355 — intervention group
Group type: EXPERIMENTAL
Intervention: Perennial immunotherapy (602 BU cumulative dose)
Number of subjects: 60
Study 8281355 — intervention group
Group type: EXPERIMENTAL
Intervention: Seasonal immunotherapy (372 BU cumulative dose)
Number of subjects: 60
Study 8281355 — intervention group
Group type: COMPARATOR
Intervention: Control group (no immunotherapy)
Number of subjects: 60
Study 3549043 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprindine
Number of subjects: 143
Study 3549043 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study 30525790 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Connects (bottom-up approach with brief home visits)
Number of subjects: 0
Study 30525790 — intervention group
Group type: EXPERIMENTAL
Intervention: North Carolina Smart Start Initiative (top-down approach to improve community-level quality of early childcare and education services)
Number of subjects: 0